GLP-3R
Late clinicalTriple GLP/GIP/Glucagon — max fat loss, appetite control
15% off your first order15% off your first order — applied at checkout
Body Composition
Drop fat while holding onto lean mass.
This stack pairs distinct pathways studied in body composition research. GLP-3R is investigated as a triple agonist at GLP-1, GIP, and glucagon receptors, with research examining appetite signaling alongside a possible glucagon-linked energy expenditure effect. CJC-1295 without DAC, a short-acting GHRH analog, and Ipamorelin, a selective ghrelin receptor agonist, act on complementary pituitary inputs studied for growth hormone release that resembles natural pulsatile patterns, with Ipamorelin reported to have minimal cortisol or prolactin response. The combination reflects research interest in metabolic and growth hormone signaling together, though human evidence for the secretagogues is limited and no combined studies are described.
Triple GLP/GIP/Glucagon — max fat loss, appetite control
GHRH analog — raises GH released per pulse
Selective GHRP — clean GH pulse
All components in stock
$317.00components, bought separately
The builder puts together a stack for this goal, with supplies, and every order ships with a protocol guide for the compounds in it.
Products described on this site are provided for research purposes. Nothing here is a medical claim, and no product is intended to diagnose, treat, cure, or prevent any disease. See our methodology for how this content is sourced and reviewed.